ReviewPharmaceuticals (Basel, Switzerland)2022

Targeting Platelet Activation Pathways to Limit Tumour Progression: Current State of Affairs.

Kutlwano R Xulu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.